Clinical Trial Update: ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of the combination of vandetanib (ZD6474), cetuximab, and irinotecan in patients with metastatic colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)
• Vandetanib (vandetanib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED